In-Hospital Mortality and Complication Rates According to Health Insurance Data in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies in Germany

BACKGROUND: Morbidity and in-hospital mortality rates of patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Germany are not known. METHODS: From 2009 to 2018 all patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Germany...

Descripción completa

Detalles Bibliográficos
Autores principales: Überrück, Lisa, Nadiradze, Giorgi, Yurttas, Can, Königsrainer, Alfred, Königsrainer, Ingmar, Horvath, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Peritoneal Surface Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184558/
https://www.ncbi.nlm.nih.gov/pubmed/33165722
http://dx.doi.org/10.1245/s10434-020-09301-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184558/
https://www.ncbi.nlm.nih.gov/pubmed/33165722
http://dx.doi.org/10.1245/s10434-020-09301-z

Ejemplares similares